StreetInsider.com News Articles

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Mon, 01 Jun 2026 08:30:00 -0400

CLEVELAND, June 01, 2026 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4).

On May 31, 2026, the Compensation Committee of Abeona’s Board of Directors granted restricted stock equity awards as a material inducement to employment to seven individuals hired by Abeona, which equity awards relate to, in the aggregate, up to 13,800 restricted shares of Abeona common stock. One-third of the shares subject to such restricted stock awards

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Mon, 01 Jun 2026 08:30:00 -0400

Form 4 ABEONA THERAPEUTICS INC. For: May 26 Filed by: Alvino Mark

Tue, 26 May 2026 16:31:00 -0400

si-local-file:///var/storage/secattach/20260526/26550569.html

Form 4 ABEONA THERAPEUTICS INC. For: May 26 Filed by: Alvino Mark

Tue, 26 May 2026 16:31:00 -0400

si-local-file:///var/storage/secattach/20260526/26550569.html

Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences

Tue, 26 May 2026 08:30:00 -0400

CLEVELAND, May 26, 2026 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that members of its management team will participate in upcoming investor conferences in June 2026:

2026 Jefferies Global Healthcare Conference: Fireside chat at 3:10 PM ET on Thursday, June 4, 2026 and investor meetings.
Goldman Sachs 47^th Annual Global Healthcare Conference 2026: Investor meetings on Monday, June 8, 2026.

A live webcast of the fireside chat can be accessed on the Investors section of the Abeona website under "Events" at https://investors.abeonatherapeutics.com/events, where a

Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences

Tue, 26 May 2026 08:30:00 -0400

CLEVELAND, May 26, 2026 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that members of its management team will participate in upcoming investor conferences in June 2026:

2026 Jefferies Global Healthcare Conference: Fireside chat at 3:10 PM ET on Thursday, June 4, 2026 and investor meetings.
Goldman Sachs 47^th Annual Global Healthcare Conference 2026: Investor meetings on Monday, June 8, 2026.

A live webcast of the fireside chat can be accessed on the Investors section of the Abeona website under "Events" at https://investors.abeonatherapeutics.com/events, where a

Form 4 ABEONA THERAPEUTICS INC. For: May 22 Filed by: Alvino Mark

Fri, 22 May 2026 17:24:00 -0400

si-local-file:///var/storage/secattach/20260522/26542929.html

Form 4 ABEONA THERAPEUTICS INC. For: May 22 Filed by: Alvino Mark

Fri, 22 May 2026 17:24:00 -0400

si-local-file:///var/storage/secattach/20260522/26542929.html

Form 144 ABEONA THERAPEUTICS INC. Filed by: Alvino Mark

Fri, 22 May 2026 16:12:00 -0400

si-local-file:///var/storage/secattach/20260522/26541748.html

Form 144 ABEONA THERAPEUTICS INC. Filed by: Alvino Mark

Fri, 22 May 2026 16:12:00 -0400

si-local-file:///var/storage/secattach/20260522/26541748.html

Form 4 ABEONA THERAPEUTICS INC. For: May 15 Filed by: Crombez Eric

Fri, 15 May 2026 17:00:00 -0400

si-local-file:///var/storage/secattach/20260515/26507506.html

Form 4 ABEONA THERAPEUTICS INC. For: May 15 Filed by: Crombez Eric

Fri, 15 May 2026 17:00:00 -0400

si-local-file:///var/storage/secattach/20260515/26507506.html

Form SCHEDULE 13G/A ABEONA THERAPEUTICS INC. Filed by: Nantahala Capital Management, LLC

Fri, 15 May 2026 16:49:00 -0400

si-local-file:///var/storage/secattach/20260515/26507226.html

Form SCHEDULE 13G/A ABEONA THERAPEUTICS INC. Filed by: Nantahala Capital Management, LLC

Fri, 15 May 2026 16:49:00 -0400

si-local-file:///var/storage/secattach/20260515/26507226.html

Form SCHEDULE 13G/A ABEONA THERAPEUTICS INC. Filed by: Nantahala Capital Partners Limited Partnership

Fri, 15 May 2026 16:41:00 -0400

si-local-file:///var/storage/secattach/20260515/26506874.html

Form SCHEDULE 13G/A ABEONA THERAPEUTICS INC. Filed by: Nantahala Capital Partners Limited Partnership

Fri, 15 May 2026 16:41:00 -0400

si-local-file:///var/storage/secattach/20260515/26506874.html

Form 144 ABEONA THERAPEUTICS INC. Filed by: Crombez Eric

Fri, 15 May 2026 16:32:00 -0400

si-local-file:///var/storage/secattach/20260515/26506418.html

Form 144 ABEONA THERAPEUTICS INC. Filed by: Crombez Eric

Fri, 15 May 2026 16:32:00 -0400

si-local-file:///var/storage/secattach/20260515/26506418.html

Form 10-Q ABEONA THERAPEUTICS INC. For: Mar 31

Wed, 13 May 2026 07:36:00 -0400

si-local-file:///var/storage/secattach/20260513/26481813.html

Form 10-Q ABEONA THERAPEUTICS INC. For: Mar 31

Wed, 13 May 2026 07:36:00 -0400

si-local-file:///var/storage/secattach/20260513/26481813.html

Abeona Therapeutics (ABEO) Tops Q1 EPS by 4c

Wed, 13 May 2026 07:32:39 -0400

Abeona Therapeutics (NASDAQ: ABEO) reported Q1 EPS of ($0.30), $0.04 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $8.72 million versus the consensus estimate of $4.62 million.

For earnings history and earnings-related data on Abeona Therapeutics (ABEO) click here.

Form 8-K ABEONA THERAPEUTICS INC. For: May 13

Wed, 13 May 2026 07:31:00 -0400

si-local-file:///var/storage/secattach/20260513/26481762.html

Form 8-K ABEONA THERAPEUTICS INC. For: May 13

Wed, 13 May 2026 07:31:00 -0400

si-local-file:///var/storage/secattach/20260513/26481762.html

Abeona Therapeutics® Reports First Quarter 2026 Results and Provides Pipeline Update

Wed, 13 May 2026 07:30:00 -0400

- Three patients treated with ZEVASKYN® in Q1 2026 -

- QTC network expands to six sites, with two new additions on the East Coast -

- In-licensed radically novel engineered T-cell technology with game changing potential in the field of solid tumors; ophthalmology programs deprioritized -

- $168.3M in cash, cash equivalents and short-term investments as of March 31, 2026 -

- Webcast today at 8:30am ET -

CLEVELAND, May 13, 2026 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today reported financial results for